NCT06076499View on ClinicalTrials.gov

A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS

Active, not recruitingOBSERVATIONAL
Enrollment

325

Participants

Timeline

Start Date

November 15, 2023

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2026

Conditions
Restless Legs Syndrome
Interventions
DEVICE

NTX100

NTX100 Tonic Motor Activation (TOMAC) System - a non-invasive peripheral nerve stimulation device programmed to deliver active stimulation.

Trial Locations (6)

29201

Bogan Sleep Consultants, LLC, Columbia

43017

Ohio Sleep Medicine and Institute, Dublin

63123

Clayton Sleep Institute, St Louis

90241

Mark J Buchfuhrer, MD Office, Downey

94583

Sleep Medicine Specialists of California, San Ramon

02459

Neurocare, Inc., Newton

Sponsors
All Listed Sponsors
lead

Noctrix Health, Inc.

INDUSTRY

NCT06076499 - A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS | Biotech Hunter | Biotech Hunter